Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 368

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial

Hajjar, Ludhmila Abrahao, Vincent, Jean Louis, Barbosa Gomes Galas, Filomena Regina, Rhodes, Andrew, Landoni, Giovanni, Osawa, Eduardo Atsushi, Melo, Renato Rosa, Sundin, Marcia Rodrigues, Grande, Solimar Miranda, Gaiotto, Fabio A., Pomerantzeff, Pablo Maria, Dallan, Luis Oliveira, Franco, Rafael Alves, Nakamura, Rosana Ely, Lisboa, Luiz Augusto, de Almeida, Juliano Pinheiro, Gerent, Aline Muller, Souza, Dayenne Hianae, Gaiane, Maria Alice, Fukushima, Julia Tizue, Park, Clarice Lee, Zambolim, Cristiane, Rocha Ferreira, Graziela Santos, Strabelli, Tânia Mara, Fernandes, Felipe Lourenco, Camara, Ligia, Zeferino, Suely, Santos, Valter Garcia, Piccioni, Marilde Albuquerque, Jatene, Fabio Biscegli, Costa Auler, Jose Otavio, Filho, Roberto Kalil · 2017 · Anesthesiology

Abstract

Background: Vasoplegic syndrome is a common complication after cardiac surgery and impacts negatively on patient outcomes. The objective of this study was to evaluate whether vasopressin is superior to norepinephrine in reducing postoperative complications in patients with vasoplegic syndrome. Methods: This prospective, randomized, double-blind trial was conducted at the Heart Institute, University of Sao Paulo, Sao Paulo, Brazil, between January 2012 and March 2014. Patients with vasoplegic shock (defined as mean arterial pressure less than 65 mmHg resistant to fluid challenge and cardiac index greater than 2.2 l · min−2 · m−2) after cardiac surgery were randomized to receive vasopressin (0.01 to 0.06 U/min) or norepinephrine (10 to 60 μg/min) to maintain arterial pressure. The primary endpoint was a composite of mortality or severe complications (stroke, requirement for mechanical ventilation for longer than 48 h, deep sternal wound infection, reoperation, or acute renal failure) within 30 days. Results: A total of 330 patients were randomized, and 300 were infused with one of the study drugs (vasopressin, 149; norepinephrine, 151). The primary outcome occurred in 32% of the vasopressin patients and in 49% of the norepinephrine patients (unadjusted hazard ratio, 0.55; 95% CI, 0.38 to 0.80; P = 0.0014). Regarding adverse events, the authors found a lower occurrence of atrial fibrillation in the vasopressin group (63.8% vs. 82.1%; P = 0.0004) and no difference between groups in the rates of digital ischemia, mesenteric ischemia, hyponatremia, and myocardial infarction. Conclusions: The authors’ results suggest that vasopressin can be used as a first-line vasopressor agent in postcardiac surgery vasoplegic shock and improves clinical outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/aln.0000000000001434

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 368

Metadata

Authors
Hajjar, L. A., Vincent, J. L., Barbosa Gomes Galas, F. R., Rhodes, A., Landoni, G., Osawa, E. A., Melo, R. R., Sundin, M. R., Grande, S. M., Gaiotto, F. A., Pomerantzeff, P. M., Dallan, L. O., Franco, R. A., Nakamura, R. E., Lisboa, L. A., de Almeida, J. P., Gerent, A. M., Souza, D. H., Gaiane, M. A., Fukushima, J. T., Park, C. L., Zambolim, C., Rocha Ferreira, G. S., Strabelli, T. M., Fernandes, F. L., Camara, L., Zeferino, S., Santos, V. G., Piccioni, M. A., Jatene, F. B., Costa Auler, J. O., & Filho, R. K.
Venue
Anesthesiology
Published
2017-01
Volume
126
Issue
1
Pages
85-93
ISSN
0003-3022 (ISSN-L)
OpenAlex
W2553631662
Cited by
368
References
25
FWCI
30.87
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial. https://app.cochat.ai/papers/10.1097/aln.0000000000001434
The paper
Hajjar, L. A., Vincent, J. L., Barbosa Gomes Galas, F. R., Rhodes, A., Landoni, G., Osawa, E. A., Melo, R. R., Sundin, M. R., Grande, S. M., Gaiotto, F. A., Pomerantzeff, P. M., Dallan, L. O., Franco, R. A., Nakamura, R. E., Lisboa, L. A., de Almeida, J. P., Gerent, A. M., Souza, D. H., Gaiane, M. A., . . . Filho, R. K. (2017). Vasopressin versus Norepinephrine in Patients with Vasoplegic Shock after Cardiac Surgery: The VANCS Randomized Controlled Trial. Anesthesiology. https://doi.org/10.1097/aln.0000000000001434

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.